EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Risk Factors of Chemotherapy-Induced Thrombocytopenia After Oxaliplatin-Containing Chemotherapy for Gastrointestinal Malignancies

Ju Li, Wanqing Wang, Kaipeng Jiang, Jiuwei Cui, Chang Wang, Tingting Liang, Yizhuo Wang, Shuhan Liu, Wenshuo Zhou

Journal of Gastrointestinal Cancer · 2024-09 · 55 (3) · 1144-1153

DOI: 10.1007/s12029-024-01059-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastrointestinal Cancer, online erschienen am 07.05.2024. Verfasst von Ju Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: The First Hospital of Jilin University, Changchun, Jilin, China. Hauptthemen laut MEDLINE: Thrombocytopenia, Oxaliplatin, Gastrointestinal Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Thrombocytopenia is among the most common chemotherapy-related hematologic toxicities. We aim to determine the predictors of oxaliplatin chemotherapy-induced thrombocytopenia in patients with gastrointestinal tumors to guide the clinic.

Methods

Clinical data of 750 patients with a malignant gastrointestinal tumor were included as the primary cohort. Basic clinical data, serological indices, and anthropometric indices of these patients were collected. According to the presence or absence of CIT, univariate analysis was performed to identify significant factors for multivariate analysis. In R language software, nomogram was constructed based on the results of multi-factor analysis, and the calibration curve and ROC curve were drawn.

Results

Univariate analysis identified 17 factors as closely related to CIT occurrence, namely age, lymph node metastasis (N) stage, metastasis (M) stage, lung metastasis, other site metastasis, chemotherapy regimen, course of treatment, total dose of oxaliplatin, AST, albumin, neutrophils, monocytes, baseline platelets, transferrin, natural killer (NK) cell, phase angle, and SMI ( P < 0.10). The binary logistic multivariate regression analysis revealed five independent risk factors for developing CIT ( P < 0.05), including the M stage, total dose of oxaliplatin, albumin, baseline thrombocyte count, and NK cell. Based on the results of multivariate logistic regression analysis, R software was used to establish a nomogram model. The calibration curve shows that the combined predictor has good consistency. The area under the ROC curve was 0.877 and the best cut-off value was 0.3579613 (sensitivity, 78.9%; specificity, 81.8%), which showed the better prediction efficiency.

Conclusion

The total dose of oxaliplatin, M stage, albumin, baseline platelet count, and NK cell was independent risk factors for CIT. The sequentially constructed histogram model had a good predictive effect on the risk of thrombocytopenia caused by oxaliplatin chemotherapy in patients with gastrointestinal malignancies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThrombocytopeniaOxaliplatinGastrointestinal NeoplasmsHumansMaleFemaleMiddle AgedRisk FactorsAgedAdultNomogramsAntineoplastic Combined Chemotherapy ProtocolsRetrospective StudiesAntineoplastic AgentsPlatelet Count

Stichwörter der Autor:innen

CancerChemotherapyRisk factorsThrombocytopenia

Substanzen

OxaliplatinAntineoplastic Agents

Autor:innen und Institutionen

  • The First Hospital of Jilin University, Changchun, Jilin, China.
  • The First Hospital of Jilin University, Changchun, Jilin, China. liangtt@jlu.edu.cn.

Zitieren

APA

Li, J., Wang, W., Jiang, K., Cui, J., Wang, C., Liang, T., Wang, Y., Liu, S., & Zhou, W. (2024). Risk Factors of Chemotherapy-Induced Thrombocytopenia After Oxaliplatin-Containing Chemotherapy for Gastrointestinal Malignancies. Journal of Gastrointestinal Cancer, 55(3), 1144-1153. https://doi.org/10.1007/s12029-024-01059-x

Vancouver

Li J, Wang W, Jiang K, Cui J, Wang C, Liang T, et al. Risk Factors of Chemotherapy-Induced Thrombocytopenia After Oxaliplatin-Containing Chemotherapy for Gastrointestinal Malignancies. Journal of Gastrointestinal Cancer. 2024;55(3):1144-1153. doi:10.1007/s12029-024-01059-x

BibTeX
@article{Li2024,
  author = {Li, Ju and Wang, Wanqing and Jiang, Kaipeng and Cui, Jiuwei and Wang, Chang and Liang, Tingting and Wang, Yizhuo and Liu, Shuhan and Zhou, Wenshuo},
  title = {Risk Factors of Chemotherapy-Induced Thrombocytopenia After Oxaliplatin-Containing Chemotherapy for Gastrointestinal Malignancies},
  journal = {Journal of Gastrointestinal Cancer},
  year = {2024},
  volume = {55},
  number = {3},
  pages = {1144--1153},
  doi = {10.1007/s12029-024-01059-x}
}
Kostenlos starten →